Under construction – not a live service
Sign in
CompletedPhase 1

A clinical study of MK-6552 in healthy adults (MK-6552-002)

Key facts

Phase
Phase 1

This trial has no sites in United States.

It has sites in one country. Choose a country to see its sites.

Trial details

Who runs it
Merck Sharp & Dohme LLC
Trial code
EU 2023-504954-37-00
Record updated
15 May 2024